Next Generation Sequencing | Deletion / Duplication | NGS & Del Dup Comprehensive |
---|---|---|
Price: |
Price: |
Price: |
CPT: |
CPT: |
CPT: |
This test analyzes three founder mutations in the Amish population related to heart disease risk: c.3330+2T>G variant in MYBPC3, c.699G>A variant in DSP, and c.451_452delCT variant in KCNQ1. Clinical overlap between these three founder mutations includes progressive heart failure, sudden cardiac death, and syncope, arrhythmia, shortness of breath, and cardiac arrest. All three founder mutations are tested at once to provide the best risk assessment for patients in the Amish community.
Type A
1 - 2 weeks